Snibe attained outstanding results across all 9 biochemistry routine assays and 18 concentration levels in this assessment with a 100% pass rate. This achievement further validates the accuracy of Snibe’s biochemical assays and our robust capability in metrological traceability.

KAING is dedicated to researching cutting-edge medical image processing algorithms, 3D display technology, and new display technologies like Mini-LED and OLED. Our mission is to deliver technologically advanced, high-quality, and reliable products to our clients.

LINKS Medical Scientific (Shanghai) Co., Ltd. (LINKS CRO) is a Contract Research Organization (CRO) headquartered in Shanghai, China. We are dedicated to providing comprehensive clinical trial services, specifically designed for high-risk implantation (intervention) medical devices. Our primary foc

The 36th World Congress of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2026) was recently held in London, UK. As one of the leading international events in obstetric and gynecological ultrasound, the congress brought together more than 2,500 clinicians, experts, resea

Regarded as a technical background company, we focus R&D and manufacturing of imaging module for medical endoscope

Offering specialised services including medical research, pre-clinical large animal testing, clinical trials and global registration.

On September 9, 2026, the Center for Medical Device Evaluation (CMDE) of the National Medical Products Administration (NMPA) issued the *Public Notice on Review Results of Applications under the Special Review Procedure for Innovative Medical Devices (No.15, 2026)*, proposing to approve eight medica

Professor Song Enming, PhD Supervisor at the Institute of Optoelectronics, Fudan University and Chief Scientist of Full-Brain Core Technology (Shanghai) Co., Ltd., will attend the conference and deliver a keynote speech entitled *Implantable Silicon-Based Neuromodulation Devices and Systems*.

On September 4, Shuli Innovation (Shanghai) Intelligent Technology Co., Ltd. completed counseling filing registration with the Shanghai Securities Regulatory Bureau, officially commencing its pre‑IPO counseling for the STAR Market, with Huatai United Securities acting as the counseling institution.

On September 1, 2026, U.S. orthopedic‑device firm Enovis Corporation officially announced that it has entered into a binding acquisition offer with French orthopedic surgical‑robot company eCential Robotics.

On September 1, 2026, Medtronic, a global medical‑technology giant, and Cornerstone Robotics, a Chinese laparoscopic surgical robot developer, officially announced a deep strategic partnership.

At the Medical‑Health Pavilion of the Changping‑Future Science City exhibition group, Chunfeng Huayu (Beijing) Intelligent Medical Technology Co., Ltd. showcased its self‑developed world‑first three‑arm surgical robot. Boasting its groundbreaking human‑shaped three‑arm architecture and end‑to‑end in

On August 7, 2026, Intuitive Surgical’s gastrointestinal endoscopic robot, the IG1000, secured FDA 510(k) clearance under clearance number K253702.

Within an implantable‑BCI system, electrodes are responsible for capturing neural signals and chips execute signal‑processing computations. The hermetic feedthrough, by contrast, serves as the critical gateway for signals to pass through the sealed housing of the implanted device.

On August 27, 2026, Apollomics (688176.SH) officially announced that its independently‑developed portable single‑use flexible blue‑light cystoscope, APLD‑2304, has successfully obtained CE certification under the EU Medical Device Regulation (MDR), alongside an ISO 13485:2016 Quality Management Syst

Recently, a domestic‑developed laparoscopic surgical robot has achieved a landmark breakthrough in core‑technology dimensions.

On August 25, Lepu Medical (300003.SZ) released its investor‑relations activity record, disclosing that the company’s interventional multi‑channel brain‑computer‑interface (BCI) product has successfully completed animal experiments and officially entered the human‑subject Investigator‑Initiated Tria

According to a recent announcement on GeRay‑Tech’s official WeChat account, its Newton‑Endo series minimally‑invasive spinal endoscopic surgical robot has successfully completed the world’s first in‑vivo animal experiment with autonomous robotic operation, under the full‑process witness of the team

Recently, the U.S. Food and Drug Administration (FDA) has granted commercialization authorization for Aletta, a fully‑autonomous blood‑collection robot developed by Dutch medical‑robotics firm Vitestro, via the De Novo classification pathway for innovative medical devices.

Invasive brain‑computer interfaces represent the most promising technical pathway for high‑fidelity neuronal signal acquisition and the restoration of impaired neural functions.